A rare presentation of undiagnosed multiple sclerosis after the COVID-19 vaccine

  • Tagliaferri A
  • Horani G
  • Stephens K
  • et al.
N/ACitations
Citations of this article
31Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Multiple sclerosis (MS) is an auto-immune mediated neurological disorder that affects the central nervous system and leads to myelin sheath destruction. The pathogenesis of MS involves T helper cells causing inflammation and eventual death of the oligodendrocytes. Etiologies for the development of MS include a combination of genetic, environmental, and immune factors. Vaccines have been proposed to increase the immune response and have reportedly activated some autoimmune disorders. Although certain vaccines such as hepatitis B have been associated with MS, studies have refuted these cases. We present a rare case of a 32-year-old patient who presented with symptoms and suggestive of MS a few days after receiving the COVID vaccine. Laboratory and imaging findings confirmed the diagnosis of MS, and she was started on steroids and discharged in a stable condition a few days after.

Cite

CITATION STYLE

APA

Tagliaferri, A. R., Horani, G., Stephens, K., & Michael, P. (2021). A rare presentation of undiagnosed multiple sclerosis after the COVID-19 vaccine. Journal of Community Hospital Internal Medicine Perspectives, 11(6), 772–775. https://doi.org/10.1080/20009666.2021.1979745

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free